Does Rallies show 13F holders for MGNX?

Yes. Rallies tracks hedge fund and 13F ownership data for MGNX, including fund names, share counts, latest tracked quarter, and position changes when available.

Is MGNX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for MGNX. It does not provide personalized investment advice.

MGNX (MacroGenics, Inc.) Stock Analysis - Hedge Fund Holdings

MacroGenics, Inc. (MGNX) is a publicly traded Healthcare sector company. As of May 21, 2026, MGNX trades at $4.18 with a market cap of $276.50M and a P/E ratio of -4.06. MGNX moved -0.88% today. Year to date, MGNX is +159.30%; over the trailing twelve months it is +184.08%. Its 52-week range spans $0.99 to $5.10. Analyst consensus is buy with an average price target of $6.33. Rallies surfaces MGNX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns MGNX stock?

Hedge funds tracked by Rallies that own MGNX include Panagora Asset. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for MacroGenics, Inc..

MGNX Key Metrics

Key financial metrics for MGNX
Metric	Value
Price	$4.18
Market Cap	$276.50M
P/E Ratio	-4.06
EPS	$-1.10
Dividend Yield	0.00%
52-Week High	$5.10
52-Week Low	$0.99
Volume	3.87K
Avg Volume	0
Revenue (TTM)	$157.08M
Net Income	$-70.36M
Gross Margin	0.00%

Top Hedge Funds Holding MGNX

Panagora Asset holds 184.91K shares of MGNX, changed +23.22% as of Mar 31, 2026.

Latest MGNX News

MacroGenics Divests Manufacturing, Extends Cash Runway to 2028 after $20.8M Q1 Revenues — May 14, 2026
MacroGenics Secures $182.5M Non-Dilutive Cash, Extends Runway to 2028 — May 13, 2026
MacroGenics Sells Maryland GMP Site to Bora for $122.5M — May 11, 2026
MacroGenics Posts $0.22 Q4 Loss, Beats Revenue Estimate by 71% at $41.2M — Mar 9, 2026
FDA Puts Partial Hold on MacroGenics’ LINNET Trial After Patient Death — Feb 24, 2026

Recent MGNX Insider Trades

HEIDEN WILLIAM K bought 49.50K (~$73.75K) on Aug 20, 2025.
HEIDEN WILLIAM K bought 50.50K (~$76.76K) on Aug 19, 2025.
Smith Beth Ann sold 423 (~$1.08K) on Feb 15, 2025.

MGNX Analyst Consensus

5 analysts cover MGNX: 0 strong buy, 2 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $6.33.

Common questions about MGNX

Who owns MGNX stock?: Hedge funds tracked by Rallies that own MGNX include Panagora Asset. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for MacroGenics, Inc..
Does Rallies show 13F holders for MGNX?: Yes. Rallies tracks hedge fund and 13F ownership data for MGNX, including fund names, share counts, latest tracked quarter, and position changes when available.
Is MGNX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for MGNX. It does not provide personalized investment advice.